Seven things to know:
1. The for-profit system reported an operating income of $1.7 billion (10.6% operating margin) in 12 months ended Dec. 31, up from $1.2 billion (8.2% margin) in the same period in 2023,
2. The system posted net revenues of $15.8 billion in 2024, a 10.8% increase year over year.
3. UHS reported total expenses of $14.1 billion, up 7.9% year over year. Salaries, wages and benefits increased 5.8% year over year to $7.5 billion. Supply expenses increased 3.6% to $1.6 billion.
4. UHS’ acute care hospitals saw adjusted admissions increase 2.9% year over year, while adjusted patient days increased by 1.8%. Net revenue per adjusted admission increased by 5.1%, while net revenue per adjusted patient day increased by 6.3%. Net revenues generated from acute care services — on a same facility basis — increased 8.5%
5. UHS is projecting net revenue between $17 billion and $17.4 billion in 2025.
6. The system expects to spend between $850 million and $1 billion on capital expenses in 2025. UHS spent $943.8 million in capital expenses in 2024 and $743 million in 2023.
7. UHS operates 28 inpatient acute care hospitals, 331 inpatient behavioral health facilities, 60 outpatient facilities, an insurance offering, and a physician network in 39 states, Washington, D.C., the United Kingdom and Puerto Rico.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
